Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat
✍ Scribed by Nima Naderi; Leila Ahmad-Molaei; Farzad Aziz Ahari; Fereshteh Motamedi
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 178 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0364-3190
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In this study, we examined the acute anticonvulsant spectrum of (1) dizocilpine (0.03-3 mg/kg), CGS 19755 (1-10 mg/kg), and 7-chlorokynurenic acid (1-100 nmol) (NMDA receptor/ionophore complex antagonists); (2) muscimol (0.1-10 nmol; direct GABA A agonist); (3) YM90K (3-10 mg/kg; AMPA receptor antag
## Abstract The present study was designed to determine the potential of CB1 cannabinoid receptor modulating compounds in the treatment of L‐3,4‐dihydroxyphenylalanine (L‐dopa)–induced dyskinesia in Parkinson's disease. In the reserpine‐treated rat model of parkinsonism, administration of a high do
## Abstract The cannabinoids (CB) modulate the extracellular signal‐regulated kinase (ERK), leading to various forms of plasticity in the brain. Little is known, however, on the in vivo short‐ and long‐term activation and regulation of the components of mitogen‐activated protein kinase (MAPK)/ERK s